Old Web
English
Sign In
Acemap
>
authorDetail
>
Mary Brigid Bradley-Garelik
Mary Brigid Bradley-Garelik
Bristol-Myers Squibb
Medicine
Stakeholder
Drug development
Commission
Paediatric oncology
2
Papers
145
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Creating a unique, multi-stakeholder Paediatric Oncology Platform to improve drug development for children and adolescents with cancer.
2015
European Journal of Cancer
Gilles Vassal
Raphaël Rousseau
Patricia Blanc
Lucas Moreno
Gerlind Bode
Stefan Schwoch
Martin Schrappe
Jeffrey Skolnik
Lothar Bergman
Mary Brigid Bradley-Garelik
Vaskar Saha
Andrew D.J. Pearson
Heinz Zwierzina
Show All
Source
Cite
Save
Citations (62)
Dasatinib 140 mg once daily versus 70 mg twice daily in patients with Ph-positive acute lymphoblastic leukemia who failed imatinib: Results from a phase 3 study.
2010
American Journal of Hematology
Michael B. Lilly
Oliver G. Ottmann
Neil P. Shah
Richard A. Larson
Josy Reiffers
Gerhard Ehninger
Martin C. Müller
A. Charbonnier
Eduardo Bullorsky
Hervé Dombret
Mary Brigid Bradley-Garelik
Chao Zhu
Giovanni Martinelli
Show All
Source
Cite
Save
Citations (83)
1